Table 4 Tumor recurrence/residual detected by 68Ga-labelled PSMA-ligand PET/CT in reference to the clinical and/or PSA level and/or radiological follow-up and/or the histopathological assessment for the patients, with the number (No.), percent (%) of the patients
Tumoural residual/recurrence by PET/CT | Positive by the reference methods (n = 29) | Negative by the reference methods (n = 1) | ||
|---|---|---|---|---|
Positive (n = 28) | 28 patients (TP) | 96.5% | 0 patient (FP) | 0% |
Negative (n = 2) | 1 patient (FN) | 3.5% | 1 patient (TN) | 100% |